12 Einträge gefunden

1. Perioperative morbidity and outcome of secondary cytoreduction for recurrent epithelial ovarian cancer.

   1. Wölber, Linn
   2. Jung, S
   3. Zu Eulenburg, Christine Gräfin
   4. Müller, Volkmar
   5. Schwarz, Jörg
   6. Jänicke, Fritz
   7. Mahner, Sven

   2010 - Forschungsinformationssystem des UKE
2. Insights into minimal residual disease in cancer patients: implications for anti-cancer therapies.

   1. Müller, Volkmar
   2. Alix-Panabières, Catherine
   3. Pantel, Klaus

   2010 - Forschungsinformationssystem des UKE
3. Comparison of microarray-based RNA expression with ELISA-based protein determination of HER2, uPA and PAI-1 in tumour tissue of patients with breast cancer and relation to outcome.

   1. Witzel, Isabell
   2. Milde-Langosch, Karin
   3. Wirtz, Ralph M
   4. Roth, Claudia
   5. Henningsen, Maike
   6. Mahner, Sven
   7. Zu Eulenburg, Christine Gräfin

   2010 - Forschungsinformationssystem des UKE
4. Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial.

   1. Riethdorf, Sabine
   2. Müller, Volkmar
   3. Zhang, Liling
   4. Rau, Thomas
   5. Loibl, Sibylle
   6. Komor, Martina
   7. Roller, Marc

   2010 - Forschungsinformationssystem des UKE
5. Serum carbonic anhydrase IX during first-line therapy of ovarian cancer.

   1. Wölber, Linn
   2. Müller, Volkmar
   3. Zu Eulenburg, Christine Gräfin
   4. Schwarz, Jörg
   5. Carney, Walter
   6. Jänicke, Fritz
   7. Milde-Langosch, Karin

   2010 - Forschungsinformationssystem des UKE
6. TIMP-1 and VEGF-165 serum concentration during first-line therapy of ovarian cancer patients.

   1. Mahner, Sven
   2. Wölber, Linn
   3. Zu Eulenburg, Christine Gräfin
   4. Schwarz, Jörg
   5. Carney, Walter
   6. Jänicke, Fritz
   7. Milde-Langosch, Karin

   2010 - Forschungsinformationssystem des UKE - frei zugänglich
7. Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer.

   1. Roth, Carina
   2. Rack, Brigitte
   3. Müller, Volkmar
   4. Janni, Wolfgang
   5. Pantel, Klaus
   6. Schwarzenbach, Heidi

   2010 - Forschungsinformationssystem des UKE - frei zugänglich
8. Final results of a phase I/II pilot study of capecitabine with or without vinorelbine after sequential dose-dense epirubicin and paclitaxel in high-risk early breast cancer.

   1. Müller, Volkmar
   2. Thomssen, Christoph
   3. Schmidt, Marcus
   4. Glados, Manfred
   5. Jackisch, Christian
   6. Heilmann, Volker
   7. Hinke, Axel

   2010 - Forschungsinformationssystem des UKE - frei zugänglich
9. The transcription factor Fra-2 promotes mammary tumour progression by changing the adhesive properties of breast cancer cells.

   1. Schröder, Christine
   2. Schumacher, Udo
   3. Müller, Volkmar
   4. Wirtz, Ralph M
   5. Streichert, Thomas
   6. Richter, Ulrich
   7. Wicklein, Daniel

   2010 - Forschungsinformationssystem des UKE
10. Expression levels of Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166) in primary breast carcinoma and distant breast cancer metastases.

    1. Henningsen, Maike
    2. Köhler, N
    3. Kersten, Jan Felix
    4. Milde-Langosch, Karin
    5. Beck, K
    6. Höller, S
    7. Müller, Volkmar

    2010 - Forschungsinformationssystem des UKE - frei zugänglich
11. HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial.

    1. Fehm, Tanja
    2. Müller, Volkmar
    3. Aktas, Bahriye
    4. Janni, Wolfgang
    5. Schneeweiss, Andreas
    6. Stickeler, Elmar
    7. Lattrich, Claus

    2010 - Forschungsinformationssystem des UKE
12. Overexpression of carbonic anhydrase IX (CAIX) in vulvar cancer is associated with tumor progression and development of locoregional lymph node metastases.

    1. Choschzick, Matthias
    2. Wölber, Linn
    3. Hess, Stephan
    4. Zu Eulenburg, Christine Gräfin
    5. Schwarz, Jörg
    6. Simon, Ronald
    7. Mahner, Sven

    2010 - Forschungsinformationssystem des UKE